“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
A 27-year-old man in England developed a blood clot in the brain and died on Apr. 20, 2021, three weeks after receiving the first dose of AstraZeneca/Oxford University’s experimental viral vectored Covid-19 vaccine Vaxzevria (also known as AZD1222), and a U.K. coroner determined his death was causally related to the vaccination. Jack Last of Stowmarket […]
There have been a number of reports published in the medical literature describing cases of thyroid autoimmunity developing in individuals, who have received different types of COVID-19 shots.1 Cases occur in individuals who have never been diagnosed with a thyroid disorder and in those whose thyroid disorders worsen after COVID vaccinations. The thyroid is an […]
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]
Some 920 applications have been filed in the United Kingdom for compensation related to injuries and deaths of people following COVID-19 vaccinations. Those applications are for financial payouts under the U.K. National Health Service’s (NHS) Vaccine Damage Payment Scheme (VDPS), which allows an individual who has allegedly been left severely disabled by a vaccine to […]
Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]
Phase III controlled trials are considered the ‘gold standard’ for assessing vaccine efficacy and safety in humans. These are the trials upon which authorities have assured the public that COVID-19 vaccines are “safe and effective.” The benefits of the vaccines in reducing disease severity and hospitalizations are well-known, but what do we know about the adverse events?Data on adverse events is vital for effective decision-making by regulators, policy makers, doctors, and patients.
Health Canada, the Canadian government’s department responsible for national health policy, earlier this month updated the product information label for Pfizer/BioNTech’s experimental messenger RNA (mRNA) biologic (also known as BNT162b2 or “Comirnaty” vaccine) to reflect reported cases of Bell’s palsy—an immune mediated neurological disorder characterized by temporary muscle weakness or paralysis on one side of […]
A recent study published by King’s College in London, which operates the ZOE COVID Study app to monitor COVID infection and vaccination rates, found that, as of July 15, 2021, there was an average of 15,537 new daily symptomatic cases of COVID-19 among partly or fully vaccinated people in the United Kingdom—an increase of 40 […]
The government of Italy has suspended AstraZeneca/Oxford University’s experimental AZD1222 COVID-19 vaccine for people under 60 years of age in that country. The decision, announced on June 11, 2021, follows the recent death of 18-year-old Camilla Canepa, who died of a cerebral due to a blood clot 16 days after receiving the first dose of […]
Hundreds of thousands of British citizens marched in central London on May 29, 2021 in a “Unite for Freedom” rally to protest against the government’s COVID-19 lockdowns, vaccine passports and other pandemic-related regulations and restrictions.1 2 Chanting “no more lockdowns” and “take your freedom back,” protesters later gathered at the Westfield shopping center, which was […]